Zde se nacházíte:
Informace o publikaci
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease
Autoři | |
---|---|
Rok publikování | 2022 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | Leukemia |
Fakulta / Pracoviště MU | |
Citace | |
www | https://www.nature.com/articles/s41375-021-01343-w |
Doi | http://dx.doi.org/10.1038/s41375-021-01343-w |
Klíčová slova | daratumumab; multiple myeloma; extramedullary disease; efficacy |
Popis | The treatment of multiple myeloma (MM) has changed substantially during the past two decades. The incorporation of novel agents into therapeutic strategies has resulted in prolonged overall survival of MM patients with approximately 15% of them being considered operationally cured. |
Související projekty: |